Merck & Co Inc
Change company Symbol lookup
Select an option...
MRK Merck & Co Inc
PCAR Paccar Inc
VMI Valmont Industries Inc
JPM JPMorgan Chase & Co
KCLI Kansas City Life Insurance Co
PRU Prudential Financial Inc
RLI Rli Corp
WRB W. R. Berkley Corp
AON Aon PLC
SMG Scotts Miracle-Gro Co
Go

Health Care : Pharmaceuticals | Large Cap Value
Company profile

Merck & Co., Inc. is a global healthcare company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through four segments: Pharmaceutical, Animal Health, Healthcare Services and Alliances. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed healthcare providers, such as health maintenance organizations, pharmacy benefit managers and other institutions. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices.

Postmarket

Last Trade
Delayed
$81.55
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$81.55
Day's Change
1.16 (1.44%)
Bid
--
Ask
--
B/A Size
--
Day's High
82.46
Day's Low
80.82
Volume
(Above Average)
Volume:
9,678,707

10-day average volume:
8,740,996
9,678,707

Company Profile

Merck & Co., Inc. is a global healthcare company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through four segments: Pharmaceutical, Animal Health, Healthcare Services and Alliances. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed healthcare providers, such as health maintenance organizations, pharmacy benefit managers and other institutions. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices.

Valuation Ratios

Price/Earnings (TTM)
17.56x
Price/Sales (TTM)
4.27x
Price/Book (MRQ)
6.92x
Price/Cash Flow (TTM)
13.25x
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

Annual growth, past 5 years
EPS
Revenue
Dividend

Short Interest

November 2020
Current Month
13.5M
Previous Month
14.8M
Percent of Float
0.53%
Days to Cover
1.7680 Days

Share Information

MRK is in a share class of common stock
Float
2.5B
Shares Outstanding
2.5B
Institutions Holding Shares
3,248
73.39%

Financial Statements

Balance sheet

Values displayed are in millions.

Income statement

Values displayed are in millions.

Cash flow

Values displayed are in millions.

Company Officers

  • Kenneth C. FrazierChmn.
  • Robert M. DavisCFO
  • Steven C. Mizell
  • Michael T. NallyExec.VP
  • Jennifer L. ZacharyExec.VP

Address

  • 2000 Galloping Hill Rd
  • Kenilworth, NJ 07033-1310
  • Phone: (908) 740-4000
  • Fax: (908) 423-1987
  • http://www.merck.com/

Insider Trading

During the most recent quarter, 597K shares were sold in insider trading.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2020. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.